1-4 of 4
Joshua T. Mendell
Close
Sort by
Journal Articles

KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation

Youl-Nam Lee, Stephanie Brandal, Pierre Noel, Erik Wentzel, Joshua T. Mendell, Michael A. McDevitt, Reuben Kapur, Melody Carter, Dean D. Metcalfe, Clifford M. Takemoto
Journal: Blood
Blood (2011) 117 (13): 3629–3640.
https://doi.org/10.1182/blood-2010-07-293548
Published: 2011
Includes: Supplemental data
Journal Articles

Pax5 Activates Oncogenic Transcription Factors of the Ets Family by Repressing the mir-15a/16-1 microRNA Cluster.

Elaine Y. Chung, Ph.D., Diana Cozma, M.D., Duonan Yu, Ph.D., Michael Dews, Ph.D., Erik A. Wentzel, Tsung-Cheng Chang, Joshua T. Mendell, M.D., Ph.D., Andrei Thomas-Tikhonenko, PhD
Journal: Blood
Blood (2007) 110 (11): 346.
https://doi.org/10.1182/blood.V110.11.346.346
Published: 2007
Journal Articles

Upregulation of SOCS-1 and Downregulation of miR-214 Correlate with Disease Course in Chronic Lymphocytic Leukemia.

Kimberly A. Jones, MD, John D. Phillips, PhD, Joshua T. Mendell, MD,PhD, Martha G. Glenn, MD, Margaret K. Yu, MD
Journal: Blood
Blood (2006) 108 (11): 4313.
https://doi.org/10.1182/blood.V108.11.4313.4313
Published: 2006
Journal Articles

DNA Methylation Inhibitors Upregulate MiRNA Expression in Patients with Chronic Lymphocytic Leukemia.

Margaret K. Yu, MD, Joshua T. Mendell, MD,PhD, Martha G. Glenn, MD, Zhong Chen, MD, Kimberly A. Jones, MD, John D. Phillips, PhD
Journal: Blood
Blood (2006) 108 (11): 2257.
https://doi.org/10.1182/blood.V108.11.2257.2257
Published: 2006